Table 2.
Biological classification based on gene ontology annotation of proteins identified by mass spectrometry analysis of immunoaffinity-purified plasma exosomes.
Biological classification | HIV-negative (n = 3) | HIV-positive (n = 4) |
---|---|---|
immune activation/inflammation | ADAM33, AZGP1, BPIFA1, BPIFB1, BTN2A2, CAMP, CD4, CSF1R, CST6, CXCL16, DDR1, DMBT1, ENO1, FERMT3, LILRB1, LILRB2, LYZ, PLTP, TFRC | ADAM33, BPIFB1, BTN2A2, CAMP, CD14, COLEC10, CPN1, CRP, CSF1R, DDR1, ENO1, FERMT3, HLA-A, HLA-B, ITGB1, ICAM2, LILRB1, PLTP, TFRC |
transmembrane signaling | CD4, EFNA4, LRP8, NOTCH4, PTRF, TFRC | EFNA4, ITGA6, LRP8, NOTCH4, TFRC |
extracellular vesicles/exosomes | ANXA2, APMAP, AZGP1, BPIFB1, CAMP, CAT, CD9, CD63, CD81, CDH1, ENO1, FERMT3, FLNA, GAPDH, HSPA5, LAMP1, LDHA, MYH9, PFN1, PKM, PRDX1, PRDX2, PXDN, RAP1A, SDCBP, TXN, UBA52, YWHAB, ZG16B | ADAM10, APMAP, ARF1, BPIFB1, CAMP, CDH1, CDC42, CRTAC1, ENO1, FERMT3, GAPDH, GPLD1, LAMP1, MYH9, PCYOX1, PKM, RAB1A, RAC1, RAP1A, SDCBP, SPTAN1, STOM, TLN1, UBA52 |
stress response | CAT, CDH1, ENO1, GAPDH, HSPA5, HSPA1L, PRDX1, PRDX2, TXN, TYMP, WARS | ADAM10, BMP1, CDH1, ENO1, GAPDH, MAP3K11, RAC1, SEPP1 |
oxidative stress | CAT, ENO1, GAPDH, PRDX1, PRDX2, PXDN, TPM1, TXN, WARS | CRP, ENO1, GAPDH, GPX3, ITGB1, RAC1, SLC25A33, SEPP1 |
fatty acid/lipid metabolism | AZGP1, CD36, CETP, DPEP3, FABP5, HGFAC, LRCOL1, PKM, PLTP | ACOX3, ADIPOQ, ANGPTL3, CD36, CETP, DPEP3, GPLD1, HADHA, HGFAC, LRCOL1, PCSK9, PKM, PLTP, SAR1A |
platelets | CD36, FERMT3, ITGA2B, ITGB3, MMRN1 | CD36, FERMT3, F11R, ITGA2B, ITGB3, PF4V1 |
PANTHER and Biobase TRANSFAC tools were used for gene ontology (GO) mapping of proteins identified by mass spectrometry analysis of IAP-purified plasma exosomes from 3 HIV-negative and 4 HIV-positive subjects in the merged datasets shown in Supplemental Tables 3 and 4. GO groups were assigned to the indicated biological functions. Individual proteins may be annotated to more than one category. Proteins identified by 2 or more unique peptides are shown in bold.